MRNA Mar 2025 65.000 put
| Previous close | 10.55 |
| Open | 10.40 |
| Bid | 10.45 |
| Ask | 10.60 |
| Strike | 65.00 |
| Expiry date | 2025-03-21 |
| Day's range | 10.40 - 10.68 |
| Contract range | N/A |
| Volume | |
| Open interest | 964 |
- Yahoo Finance Video
Moderna stock slides on downgrades tied to profitability delay
Moderna (MRNA) is receiving bearish reviews from Wall Street following the company's announcement it will be slashing it's research and development budget. The pharmaceutical company has received downgrades from both Jefferies (JEF) and JPMorgan (JPM), sending shares lower in pre-market trading. JPMorgan has downgraded Moderna's rating to Underweight from Neutral, while also reducing its price target from $88 to $70. Similarly, Jefferies downgraded the stock to Hold from Buy, with a price target cut from $120 to $65. The primary reason cited by both firms for their downgrades is Moderna's recent announcement that it's pushing back its timeline to reach break-even profitability. The company now expects to achieve this milestone in 2028, two years later than the previously projected 2026. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Angel Smith
- Yahoo Finance Video
Nvidia, August PPI and jobless claims ahead of Fed cut: Morning Brief
US stocks were mixed heading into Thursday's session, with the S&P 500 (^GSPC) and Nasdaq Composite (^IXIC) up, extending Wednesday’s gains, while the Dow Jones Industrial Average (^DJI) hovered below its flat line. Top Wall Street experts join Morning Brief hosts Seana Smith and Brad Smith to discuss the latest economic data, demand for Nvidia’s (NVDA) chips, a potential Boeing (BA) union strike, and top trending stocks. The Producer Price Index (PPI) showed prices increase by 0.2% month-over-month and 1.7% year-over-year in August. Initial jobless claims also came out above estimates for the prior week at 230,000, compared to the 227,000 expected. The new data comes after Wednesday’s in-line Consumer Price Index (CPI) print and ahead of the Federal Reserve's September FOMC meeting next week. Oxford Economics chief economist Ryan Sweet tells the Morning Brief team that the data is a "slam dunk" for a 25-basis-point interest rate cut from the Fed next week. KeyBanc Capital Markets equity research analyst John Vinh joins the Morning Brief to discuss competition among chipmakers during the ongoing artificial intelligence (AI) race after Nvidia CEO Jensen Huang’s comments about demand outpacing supply sent the chipmaker’s stock higher. Investors are watching Boeing (BA) as factory workers vote on the tentative labor agreement today, with a potential strike of 33,000 union members still looming. The Morning Brief team examines the morning's stock moves of the top trending tickers, including Kroger’s (KR) earnings-fueled gains and Moderna’s (MRNA) tumble. Other top trending stocks on the Yahoo Finance platform include Norfolk Southern (NSC) and 7-Eleven parent company Seven & I Holding (SVNDY). This post was written by Naomi Buchanan
Investor's Business DailyModerna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day
Moderna stock tumbled again Friday on a series of downgrades and price-target cuts following a "tough update" at its R&D Day.
